The Role of Dopaminergic Transmission Through D1-like and D2-like Receptors in Amphetamine-induced Rat Ultrasonic Vocalizations
Overview
Affiliations
Rationale: Systemic amphetamine (AMPH) administration increases the rate of 50-kHz ultrasonic vocalizations (USVs) in adult rats and preferentially enhances the 'trill' subtype; these effects of AMPH critically depend on noradrenergic transmission, but the possible contributions of dopamine are unclear.
Objective: To assess the role of dopamine in 50-kHz USVs emitted drug-free and following systemic AMPH administration.
Methods: Adult male Long-Evans rats pre-selected for high AMPH-induced calling rates were tested with AMPH (1 mg/kg, intraperitoneal (IP)) and saline following pretreatment with the following dopamine receptor antagonists: SCH 23390 (0.005-0.02 mg/kg, subcutaneous (SC)), SCH 39166 (0.03-0.3 mg/kg, SC), haloperidol (0.1, 0.2 mg/kg, IP), sulpiride (20-80 mg/kg, SC), raclopride (0.1-0.5 mg/kg, SC), clozapine (4 mg/kg, SC), risperidone (0.5 mg/kg, SC), and pimozide (1 mg/kg, IP). The dopamine and noradrenaline reuptake inhibitors (GBR 12909 and nisoxetine, respectively) were also tested, alone and in combination.
Results: SCH 23390, SCH 39166, haloperidol, and raclopride dose-dependently inhibited vocalizations under AMPH and suppressed the proportion of trill calls. Sulpiride, however, had no discernable effect on call rate or profile, even at a high dose that reduced locomotor activity. Single doses of clozapine, risperidone, and pimozide all markedly decreased calling under saline and AMPH. Finally, GBR 12909 and nisoxetine failed to promote 50-kHz USVs detectably or alter the subtype profile, when tested alone or in combination.
Conclusions: The rate of 50-kHz USVs and the call subtype profile following systemic AMPH administration depends on dopaminergic neurotransmission through D1-like and D2-like receptors. However, inhibiting dopamine and/or noradrenaline reuptake appears insufficient to induce calling.
Erden L, Sundarakrishnan A, Clarke P J Psychopharmacol. 2024; 38(11):1025-1041.
PMID: 39129423 PMC: 11528876. DOI: 10.1177/02698811241268894.
Serra M, Costa G, Onaivi E, Simola N Int J Neuropsychopharmacol. 2024; 27(2).
PMID: 38174899 PMC: 10852626. DOI: 10.1093/ijnp/pyae001.
50-kHz ultrasonic vocalizations do not signal social anhedonia in transgenic DISC1 rats.
Seidisarouei M, Schable S, van Wingerden M, Trossbach S, Korth C, Kalenscher T Brain Behav. 2023; 13(5):e2984.
PMID: 37016810 PMC: 10176014. DOI: 10.1002/brb3.2984.
Champeil-Potokar G, Kreichati L, Rampin O, Denis I, Darcel N, Bombail V Front Behav Neurosci. 2023; 17:1089631.
PMID: 36815182 PMC: 9939450. DOI: 10.3389/fnbeh.2023.1089631.
Sundarakrishnan A, Clarke P PLoS One. 2022; 17(10):e0276743.
PMID: 36301879 PMC: 9612506. DOI: 10.1371/journal.pone.0276743.